Standout Papers
Immediate Impact
1 by Nobel laureates 9 from Science/Nature 61 standout
Citing Papers
Renal cell carcinoma
2024 Standout
Arginine reprograms metabolism in liver cancer via RBM39
2023 Standout
Works of Colin Hessel being referenced
Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase III CELESTIAL trial.
2018
Cabozantinib in Progressive Medullary Thyroid Cancer
2013 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Colin Hessel | 570 | 582 | 398 | 696 | 25 | 2.0k | |
| Sophie Prévôt | 156 | 448 | 601 | 831 | 64 | 3.0k | |
| Abha G. Singh | 286 | 234 | 396 | 643 | 28 | 2.4k | |
| Seymour Grufferman | 416 | 856 | 252 | 517 | 73 | 2.8k | |
| Michael Collins | 338 | 1390 | 656 | 311 | 28 | 2.6k | |
| Ellen G. Feigal | 370 | 1494 | 727 | 471 | 41 | 2.7k | |
| Susanne M. Schmidt | 456 | 399 | 469 | 607 | 30 | 1.9k | |
| Khee‐Chee Soo | 570 | 693 | 273 | 380 | 62 | 2.5k | |
| Harold S. Ballard | 257 | 461 | 209 | 565 | 44 | 2.6k | |
| Peter Guest | 584 | 459 | 228 | 257 | 38 | 1.5k | |
| Paul J. Sinnott | 242 | 286 | 348 | 532 | 24 | 2.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...